Tenet Healthcare Corporation New (THC) is a publicly traded Healthcare sector company. As of July 5, 2026, THC trades at $203.72 with a market cap of $17.55B and a P/E ratio of 13.05. THC moved +6.55% today. Year to date, THC is +1.20%; over the trailing twelve months it is +18.29%. Its 52-week range spans $109.82 to $247.21. Analyst consensus is strong buy with an average price target of $243.57. Rallies surfaces THC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tenet Fintech Refiles Q2-2025 Financials to Fix Segment Revenue Discrepancy: Tenet Fintech Group refiled its Q2-2025 financial statements on June 26, 2026 to correct a software error that misaligned total revenue in segment reporting Note 24 with the consolidated profit and loss statement. Shareholders should disregard the June 24 version and refer to the corrected filing for accurate figures.
| Metric | Value |
|---|---|
| Price | $203.72 |
| Market Cap | $17.55B |
| P/E Ratio | 13.05 |
| EPS | $15.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $247.21 |
| 52-Week Low | $109.82 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $21.31B |
| Net Income | $2.37B |
| Gross Margin | 0.00% |
14 analysts cover THC: 0 strong buy, 13 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $243.57.